StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) Receives Positive CHMP Opinion on Updated Truvada Marketing Terms
July 22, 2016 7:13 AM
On 21 July 2016, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Next Articles
Jefferies Remains Sidelined on Gilead Sciences (GILD) Following 2Q - PT to $93
July 26, 2016 9:15 AM
Gilead (GILD) Receives Updated CHMP Recommendations on Zydelig as CLL, Follicular Lymphoma Treatment
July 22, 2016 7:19 AM